Abstract:You have accessJournal of UrologyBenign Prostatic Hyperplasia: Basic Research & Pathophysiology (MP06)1 Apr 2019MP06-08 THE METABOLIC HORMONE LEPTIN PROMOTES PROSTATE SMOOTH MUSCLE CONTRACTION AND INDUCES PROLIFERATION OF PROSTATE STROMAL CELLS Xiaolong Wang*, Yiming Wang, Christian Gratzke, Anna Ciotkowska, Qingfeng Yu, Ruixao Wang, Bingsheng Li, Frank Strittmatter, Christian G. Stief, and Martin Hennenberg Xiaolong Wang*Xiaolong Wang* More articles by this author , Yiming WangYiming Wang More articles by this author , Christian GratzkeChristian Gratzke More articles by this author , Anna CiotkowskaAnna Ciotkowska More articles by this author , Qingfeng YuQingfeng Yu More articles by this author , Ruixao WangRuixao Wang More articles by this author , Bingsheng LiBingsheng Li More articles by this author , Frank StrittmatterFrank Strittmatter More articles by this author , Christian G. StiefChristian G. Stief More articles by this author , and Martin HennenbergMartin Hennenberg More articles by this author View All Author Informationhttps://doi.org/10.1097/01.JU.0000555000.19794.faAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVES: Leptin is a metabolic peptide hormone produced by adipocytes, with assumed roles in proflieration of prostate cancer cells and of prostate cells in animal models of benign prostatic hyperplasia (BPH). Thus, a role of leptin as a molecular link connecting BPH and lower urinary tract symptoms (LUTS) suggestive of BPH with metabolic syndrom appears possible/feasible, but is still unknown. In fact, a connection between metabolic syndrome and BPH/LUTS is becoming increasingly evident from epidemiologic studies. Key factors of LUTS suggestive of BPH are an increased prostate smooth muscle tone, and prostate enlargement, which may both contribute to bladder outlet obstruction. Here, we examined the effects of leptin on contraction of human prostate smooth muscle and on growth of stromal cells. METHODS: Human prostate tissues were obtained from patients undergoing radical prostatectomy. Contractions of prostate strips were studied in an organ bath, using tissues from n=5 patients for each control and leptin group. Proliferation and viability of human prostate stromal cells (WPMY-1) were assessed by EdU and CCK-8 assays (five independent experiments for each). Mitochondrial-related apoptosis was examined by near-infrared (NIR) fluorescent dye and analysis by flow cytometry (FACS). RESULTS: Electric field stimulation induced frequency-dependent, neurogenic contractions of human prostate tissues. These contractions were enhanced concentration-dependently by leptin (50 nM, 100 nM), which was significant using 100 nM of leptin (p<0.05 at 16 Hz for leptin vs. control, with 47±7% of KCl-induced contraction in control, and 99.8±22% in leptin group). As shown by CCK-8 assay, leptin increased the viability of WPMY-1 cells, which was observed at different concentrations (6.25-50 ng/ml), and with similar levels of viability at all concentrations. Leptin-induced proliferation (24 h) was confirmed by EdU assay (p=0.024 at 25 ng/ml leptin, with 54 ±8.8% of cells under proliferation in control group, and 68 ±5.9% in leptin-stimulated cells). Leptin (25 ng/ml) increased NIR stain intensity in FACS analysis (p=0.035), reflecting attenuated apoptosis in WPMY-1 cells. CONCLUSIONS: Leptin promotes smooth muscle contraction and growth of stromal cells in the human prostate, suggesting that leptin might be an important factor aggravating LUTS/BPH in obese male patients. Patients suffering from metabolic syndrom plus LUTS/BPH may profit from leptin management. The leptin system in LUTS/BPH merits further consideration. Source of Funding: Deutsche Forschungsgemeinschaft (DFG), Chinese Scholarship Council (CSC) Munich, Germany© 2019 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 201Issue Supplement 4April 2019Page: e50-e50 Advertisement Copyright & Permissions© 2019 by American Urological Association Education and Research, Inc.MetricsAuthor Information Xiaolong Wang* More articles by this author Yiming Wang More articles by this author Christian Gratzke More articles by this author Anna Ciotkowska More articles by this author Qingfeng Yu More articles by this author Ruixao Wang More articles by this author Bingsheng Li More articles by this author Frank Strittmatter More articles by this author Christian G. Stief More articles by this author Martin Hennenberg More articles by this author Expand All Advertisement PDF downloadLoading ...

MP45-10 BLEBBISTATIN MODULATES PROSTATIC CELL GROWTH AND CONTRACTILITY THROUGH MYOSIN II SIGNALING

Blebbistatin modulates prostatic cell growth and contrapctility through myosin II signaling.

MP17-19 THE EXPRESSION AND FUNCTIONAL ACTIVITIES OF SMOOTH MUSCLE MYOSIN AND NON-MUSCLE MYOSIN ISOFORMS IN RAT PROSTATE

Alteration of the Expression and Functional Activities of Myosin II Isoforms in Enlarged Hyperplastic Prostates

Testosterone Regulates Myosin II Isoforms Expression and Functional Activity in the Rat Prostate.

Changes in the expression and functional activities of Myosin II isoforms in human hyperplastic prostate

MP06-08 THE METABOLIC HORMONE LEPTIN PROMOTES PROSTATE SMOOTH MUSCLE CONTRACTION AND INDUCES PROLIFERATION OF PROSTATE STROMAL CELLS

1565 TESTOSTERONE REGULATES SMOOTH MUSCLE CONTRACTILE PATHWAYS IN THE RAT PROSTATE EMPHASIS ON PHOSPHODIESTERASE V (PDE5) SIGNALING

In Vitro And In Vivo Relaxation Of Corpus Cavernosum Smooth Muscle By The Selective Myosin Ii Inhibitor, Blebbistatin

MP44-10 CD8+ T CELLS PROMOTE PROLIFERATION OF BENIGN PROSTATIC HYPERPLASIA EPITHELIAL CELLS IN THE CONDITION OF LOW ANDROGEN VIA MODULATION OF CCL5 -> STAT5 -> CYCLIN D1 SIGNALING

MP06-12 GHRELIN-MEDIATED PROMOTION OF PROSTATE GROWTH AND PROSTATE SMOOTH MUSCLE CONTRACTION: EVIDENCE FROM FUNCTIONAL, IN VIVO, AND GENOMIC APPROACHES

Smoothened inhibition leads to decreased cell proliferation and suppressed tissue fibrosis in the development of benign prostatic hyperplasia

MP06-09 SENESCENT PROSTATIC EPITHELIAL CELLS INDUCE PROLIFERATION OF FIBROBLAST DURING THE PROGRESSION OF BENIGN PROSTATIC HYPERPLASIA

MP45-15 TRANSFORMING GROWTH FACTOR BETA 1 INCREASES BENIGN PROSTATIC LUMINAL EPITHELIAL CELL LAYER PERMEABILITY

S100A4 modulates cell proliferation, apoptosis and fibrosis in the hyperplastic prostate

Upregulated bone morphogenetic protein 5 enhances proliferation and epithelial–mesenchymal transition process in benign prostatic hyperplasia via BMP/Smad signaling pathway

Blebbistain, A Myosin Ii Inhibitor, As A Novel Strategy To Regulate Detrusor Contractility In A Rat Model Of Partial Bladder Outlet Obstruction

Benign prostatic hyperplasia (BPH) epithelial cell line BPH-1 induces aromatase expression in prostatic stromal cells via prostaglandin E2.

In vitro and in vivo relaxation of urinary bladder smooth muscle by the selective myosin II inhibitor, blebbistatin.

1130 STREPTOZOTOCIN-INDUCED TYPE 1 DIABETES IN RAT ALTERS SMOOTH MUSCLE MYOSIN ISOFORM COMPOSITION TO A MORE CONTRACTILE PHENOTYPE AND INCREASES SENSITIVITY TO THE MYOSIN II SPECIFIC INHIBITOR BLEBBISTATIN

1420 TANSHINONE IIA INHIBITS ESTROGEN/ANDROGEN INDUCED PROSTATIC STROMAL HYPERPLASIA